Roche's Trontinemab Raises the Bar for Alzheimer's Amyloid Clearance Alzheimer’s disease treatments may be on the cusp of a major breakthrough, thanks to Roche’s innovative antibody, trontinemab . This next-generation therapy has shown remarkable speed and effectivenes... Alzheimer’s amyloid plaques blood-brain barrier clinical trials drug development neurodegeneration trontinemab
How Sugars on Cell Surfaces Could Unlock New Paths to Brain Resilience What if a crucial piece in the puzzle of brain aging has been hiding in plain sight, overlooked sugars on the surfaces of our brain cells. While past research zeroed in on proteins and DNA, emerging s... Alzheimer's blood-brain barrier brain aging cell surface sugars cognitive decline drug delivery glycocalyx neurodegeneration